Abstract
We aimed to identify the incidence rate of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients treated with entecavir or tenofovir in South Korea, and to identify predictors of HCC development in these patients. Between January 2007 and December 2015, 582 CHB patients initially received entecavir (n = 406, 69.8%) or tenofovir (n = 176, 30.2%) for CHB. During a median follow-up of 57.1 months, HCC developed in 38 (6.5%) of the 582 patients, regardless of antiviral agent type. Entecavir- and tenofovir-treated patients had similar HCC development rates (P = 0.471). For the 582 patients, 2-, 4-, and 6-year cumulative HCC development rates were 2.6%, 4.4%, and 8.3%, respectively, and the 2-, 4-, and 6-year cumulative HCC development rates of patients with liver cirrhosis were significantly greater than those of patients without liver cirrhosis (6.2%, 9.8%, and 18.4% vs. 0.3%, 1.1%, and 2.2%, respectively; P < 0.001). Older (≥60 years) patients, regardless of the presence of cirrhosis, and cirrhotic patients aged ≥40 years showed significantly higher risk of HCC development compared to others (both P < 0.05). Multivariate analysis showed that an older age (≥50 years; hazard ratio [HR] 5.02, P = 0.009), and the presen...Continue Reading
References
Aug 1, 1989·Radiology·A Di LelioL Beretta
Oct 1, 1996·Gastroenterology·J BruixJ Rodés
Jul 19, 2002·The New England Journal of Medicine·Hwai-I YangUNKNOWN Taiwan Community-Based Cancer Screening Project Group
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Oct 8, 2004·The New England Journal of Medicine·Yun-Fan LiawUNKNOWN Cirrhosis Asian Lamivudine Multicentre Study Group
Apr 7, 2005·Intervirology·Byung-Cheol SongHeung Kim
May 6, 2005·Gut·M-F YuenC-L Lai
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Chien-Jen ChenUNKNOWN REVEAL-HBV Study Group
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard K SterlingUNKNOWN APRICOT Clinical Investigators
Nov 17, 2006·Journal of Hepatology·Shi-Ming LinYun-Fan Liaw
Nov 7, 2007·Gastroenterology·Robert G GishHelena Brett-Smith
Dec 21, 2007·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN Globe Study Group
Dec 22, 2007·Journal of Hepatology·Giovanna FattovichFrancesco Donato
Jul 29, 2008·Alimentary Pharmacology & Therapeutics·J J Y SungH L Y Chan
Aug 13, 2008·Journal of the National Cancer Institute·Hwai-I YangUNKNOWN REVEAL-HBV Study Group
Nov 4, 2008·Journal of Hepatology·Man-Fung YuenChing-Lung Lai
Dec 5, 2008·The New England Journal of Medicine·Patrick MarcellinFranck Rousseau
Jul 8, 2009·The Korean Journal of Hepatology·Ji-Hyun ChoHaak-Cheoul Kim
Jan 6, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ting-Tsung ChangUchenna Iloeje
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent Wai-Sun WongTony Shu-Kam Mok
May 21, 2010·Journal of Hepatology·George V PapatheodoridisAnna Lok
Jul 6, 2010·Gastroenterology·Gloria WooMurray Krahn
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ting-Tsung ChangBruce Kreter
Feb 15, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zhong-Hua LinShi-Ying Xuan
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Apr 19, 2011·The Lancet Oncology·Hwai-I YangUNKNOWN REACH-B Working Group
Jan 26, 2012·Vaccine·J J OttS T Wiersma
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Dec 6, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tetsuya HosakaHiromitsu Kumada
Dec 14, 2012·Lancet·Patrick MarcellinE Jenny Heathcote
Dec 19, 2012·Lancet·Rafael LozanoZiad A Memish
May 30, 2013·Alimentary Pharmacology & Therapeutics·A K SingalR J Fontana
May 17, 2014·World Journal of Gastroenterology : WJG·Mustafa Sunbul
Jul 12, 2014·Gut·Pauline ArendsUNKNOWN VIRGIL Surveillance Study Group
Jul 17, 2015·Cancer·W Ray KimPatrick Marcellin
Aug 8, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kyu Sik JungKwang-Hyub Han
Nov 14, 2015·Hepatology International·S K SarinJ H Kao
Nov 14, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norah A TerraultUNKNOWN American Association for the Study of Liver Diseases
Dec 19, 2015·Journal of Hepatology·George PapatheodoridisPietro Lampertico
Apr 6, 2016·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver
Apr 22, 2017·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Citations
Oct 4, 2018·Alimentary Pharmacology & Therapeutics·Leanne Stratton, Andrew Bathgate
Apr 29, 2020·Journal of Gastroenterology and Hepatology·Cheng-Hao TsengHashem B El-Serag
May 31, 2019·BMC Cancer·Zeyu ZhangYun Huang
Dec 18, 2019·Gut·Yu-Xian TengJian-Hong Zhong
Mar 18, 2020·Journal of Gastroenterology and Hepatology·Lihu GuQili Yu
Aug 13, 2020·Scientific Reports·Yeonjung HaSeong Gyu Hwang
Sep 26, 2020·Journal of Gastroenterology·Terry Cheuk-Fung YipGrace Lai-Hung Wong
Apr 12, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shravan DaveRohit Loomba
Oct 3, 2020·The Lancet. Gastroenterology & Hepatology·Cheng-Hao TsengMindie H Nguyen
Apr 14, 2021·Journal of Korean Medical Science·HeeKyoung Choi, Gi Hyeon Seo
Jun 24, 2021·Clinical and Molecular Hepatology·Sung Won LeeYoung-Suk Lim
Apr 23, 2021·Journal of Clinical Gastroenterology·Seogsong JeongWon Kim